Title and Organization:
Chandrabali Ghose is the founder and CEO of Bioharmony Therapeutics, an early-stage biotech startup specializing in the development of novel antimicrobials to combat drug-resistant bacterial infections. Chandra spent 8 years at the Aaron Diamond AIDS Research Center, an affiliate of Rockefeller University, where she focused her research on developing life-saving vaccines. Prior to that, Chandra was a postdoctoral fellow at Harvard Medical School in the Division of Infectious Diseases, Massachusetts General Hospital. Chandra earned her PhD from New York University School of Medicine in microbiology and her bachelor’s degree from Saint Louis University in biology and theology, splitting her time between the Missouri and Spain campuses. Dr. Ghose has published high-impact peer-reviewed articles and book chapters in the field of infectious diseases and has received many awards for her scientific and entrepreneurial contributions from organizations that include New York University, the Infectious Diseases Society of America, Hello Tomorrow Global Challenge, and the Mid-Atlantic Bio Angels First Pitch. Dr. Ghose has volunteered her time at the C. Diff Foundation, NYAS NEXXT mentoring program, and at the Pew Charitable Trust’s program of “Supermoms against Superbugs” to raise awareness about antibiotic resistance, a cause she is passionate about. Chandra is a Fellow of the fourth class of the Health Innovators Fellowship and a member of the Aspen Global Leadership Network.